financetom
Business
financetom
/
Business
/
Science Applications International Fiscal Q1 Adjusted Earnings, Revenue Decline; Fiscal 2025 Guidance Reiterated
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Science Applications International Fiscal Q1 Adjusted Earnings, Revenue Decline; Fiscal 2025 Guidance Reiterated
Jun 3, 2024 5:02 AM

07:40 AM EDT, 06/03/2024 (MT Newswires) -- Science Applications International ( SAIC ) reported fiscal Q1 adjusted earnings Monday of $1.92 per diluted share, down from $2.14 a year earlier.

Analysts polled by Capital IQ expected $1.92.

Revenue for the fiscal quarter ended May 3 was $1.85 billion, down from $2.03 billion a year earlier.

Analysts surveyed by Capital IQ expected $1.84 billion.

For fiscal 2025, the defense contractor reiterated its previous guidance of adjusted earnings of $8.00 to $8.20 per diluted share on revenue of $7.35 billion to $7.50 billion. Analysts polled by Capital IQ expect adjusted earnings of $8.10 per share on revenue of $7.45 billion.

Price: 130.00, Change: -4.65, Percent Change: -3.45

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Defense Metals Signs MOU with Sask. Research Council to Enhance Rare Earth Element Supply Chain
Update: Defense Metals Signs MOU with Sask. Research Council to Enhance Rare Earth Element Supply Chain
Sep 29, 2024
12:01 PM EDT, 09/27/2024 (MT Newswires) -- Defense Metals ( DFMTF ) late on Thursday said it signed a memorandum of understanding with the Saskatchewan Research Council (SRC) to help strengthen the rare earth element supply chain in Canada. The MOU outlines a framework for Defense Metals ( DFMTF ) and SRC to leverage their capabilities in the supply and...
Ryde Closes $4.5 Million Public Offering
Ryde Closes $4.5 Million Public Offering
Sep 29, 2024
12:38 PM EDT, 09/27/2024 (MT Newswires) -- Ryde Group ( RYDE ) on Friday announced the closing of a $4.5 million public offering. The company issued 5.3 million units at $0.85 each. Each unit is made up of a Class A common share and a warrant that can be exchanged for a common stock at $0.85 apiece. Shares of the...
Correction: EnVVeno Medical Prices $15 Million Public Offering
Correction: EnVVeno Medical Prices $15 Million Public Offering
Sep 29, 2024
01:03 PM EDT, 09/27/2024 (MT Newswires) -- (Corrects the company name in the headline.) EnVVeno Medical ( NVNO ) said Thursday it has priced a public offering of about 4.3 million common shares or pre-funded warrants at $3.50 per share for expected gross proceeds of about $15 million. The underwriter has been granted a 30-day option to purchase up to...
Cytokinetics New Analysis of Heart Medication Study Shows Beneficial Changes
Cytokinetics New Analysis of Heart Medication Study Shows Beneficial Changes
Sep 29, 2024
12:40 PM EDT, 09/27/2024 (MT Newswires) -- Cytokinetics ( CYTK ) said Friday that findings from a new analysis of phase 3 trial of aficamten, its investigational drug for treating heart muscle thickening, showed beneficial changes. Cytokinetics ( CYTK ) said the analysis showed about 84% of patients treated with aficamten experienced favorable effects in at least one of the...
Copyright 2023-2025 - www.financetom.com All Rights Reserved